Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 394

1.

Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients.

van der Heijden M, de Jong MC, Verhagen CVM, de Roest RH, Sanduleanu S, Hoebers F, Leemans CR, Brakenhoff RH, Vens C, Verheij M, van den Brekel MWM.

Cancers (Basel). 2019 Apr 25;11(4). pii: E583. doi: 10.3390/cancers11040583.

2.

Health-related and cancer-related Internet use by patients treated with total laryngectomy.

van Uden-Kraan CF, Jansen F, Lissenberg-Witte BI, Eerenstein SEJ, Leemans CR, Verdonck-de Leeuw IM.

Support Care Cancer. 2019 Apr 16. doi: 10.1007/s00520-019-04757-6. [Epub ahead of print]

PMID:
30993449
3.

Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040).

Pai SI, Faivre S, Licitra L, Machiels JP, Vermorken JB, Bruzzi P, Gruenwald V, Giglio RE, Leemans CR, Seiwert TY, Soulieres D.

J Immunother Cancer. 2019 Apr 3;7(1):96. doi: 10.1186/s40425-019-0578-0.

4.

Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.

Martens RM, Noij DP, Koopman T, Zwezerijnen B, Heymans M, de Jong MC, Hoekstra OS, Vergeer MR, de Bree R, Leemans CR, de Graaf P, Boellaard R, Castelijns JA.

Eur J Radiol. 2019 Apr;113:39-50. doi: 10.1016/j.ejrad.2019.01.031. Epub 2019 Feb 4.

PMID:
30927958
5.

Stepped care targeting psychological distress in head and neck cancer and lung cancer patients: which groups specifically benefit? Secondary analyses of a randomized controlled trial.

Jansen F, Lissenberg-Witte BI, Krebber AMH, Cuijpers P, de Bree R, Becker-Commissaris A, Smit EF, van Straten A, Eeckhout GM, Beekman ATF, Leemans CR, Verdonck-de Leeuw IM.

Support Care Cancer. 2019 Mar 27. doi: 10.1007/s00520-019-04714-3. [Epub ahead of print]

PMID:
30915569
6.

Factors associated with depression over time in head and neck cancer patients: A systematic review.

Korsten LHA, Jansen F, de Haan BJF, Sent D, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM.

Psychooncology. 2019 Mar 13. doi: 10.1002/pon.5058. [Epub ahead of print] Review.

PMID:
30865357
7.

Swallowing and Voice Outcomes following Treatment of Hypopharyngeal Cancer: The Need for Supervised Rehabilitation.

Eerenstein SEJ, Verdonck-de Leeuw IM, Leemans CR.

Adv Otorhinolaryngol. 2019;83:118-125. doi: 10.1159/000492355. Epub 2019 Feb 12. Review.

PMID:
30754043
8.

Depth of invasion in patients with early stage oral cancer staged by sentinel node biopsy.

den Toom IJ, Janssen LM, van Es RJJ, Karagozoglu KH, de Keizer B, van Weert S, Willems SM, Bloemena E, Leemans CR, de Bree R.

Head Neck. 2019 Jan 28. doi: 10.1002/hed.25665. [Epub ahead of print]

PMID:
30688384
9.

Assessment of Neurocognitive Impairment and Speech Functioning Before Head and Neck Cancer Treatment.

Piai V, Prins JB, Verdonck-de Leeuw IM, Leemans CR, Terhaard CHJ, Langendijk JA, Baatenburg de Jong RJ, Smit JH, Takes RP, Kessels RPC.

JAMA Otolaryngol Head Neck Surg. 2019 Jan 24. doi: 10.1001/jamaoto.2018.3981. [Epub ahead of print]

PMID:
30676629
10.

Quality assurance in head and neck cancer surgery: where are we, and where are we going?

Simon C, Dietz A, Leemans CR.

Curr Opin Otolaryngol Head Neck Surg. 2019 Apr;27(2):151-156. doi: 10.1097/MOO.0000000000000519.

PMID:
30664051
11.

Referrals for head and neck cancer in England and The Netherlands: an international qualitative study of the views of secondary-care surgical specialists.

Langton S, Rijken JA, Bankhead CR, Plüddemann A, Leemans CR.

Br J Oral Maxillofac Surg. 2019 Feb;57(2):116-124. doi: 10.1016/j.bjoms.2018.12.012. Epub 2019 Jan 17. Review.

PMID:
30661829
12.

Increased Mortality in SDHB but Not in SDHD Pathogenic Variant Carriers.

Rijken JA, van Hulsteijn LT, Dekkers OM, Niemeijer ND, Leemans CR, Eijkelenkamp K, van der Horst-Schrivers ANA, Kerstens MN, van Berkel A, Timmers HJLM, Kunst HPM, Bisschop PHLT, Dreijerink KMA, van Dooren MF, Hes FJ, Jansen JC, Corssmit EPM, Hensen EF.

Cancers (Basel). 2019 Jan 17;11(1). pii: E103. doi: 10.3390/cancers11010103.

13.

Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.

Martens RM, Noij DP, Ali M, Koopman T, Marcus JT, Vergeer MR, de Vet H, de Jong MC, Leemans CR, Hoekstra OS, de Bree R, de Graaf P, Boellaard R, Castelijns JA.

Oral Oncol. 2019 Jan;88:75-83. doi: 10.1016/j.oraloncology.2018.11.005. Epub 2018 Nov 22. Review.

14.

Unmet supportive care needs in patients treated with total laryngectomy and its associated factors.

Jansen F, Eerenstein SEJ, Lissenberg-Witte BI, van Uden-Kraan CF, Leemans CR, Leeuw IMV.

Head Neck. 2018 Dec;40(12):2633-2641. doi: 10.1002/hed.25358. Epub 2018 Nov 21.

PMID:
30462875
15.

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.

Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group.

Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15.

16.

Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining.

de Boer DV, Brink A, Buijze M, Stigter-van Walsum M, Hunter KD, Ylstra B, Bloemena E, Leemans CR, Brakenhoff RH.

Mol Cancer Res. 2019 Jan;17(1):120-130. doi: 10.1158/1541-7786.MCR-18-0445. Epub 2018 Sep 17.

PMID:
30224542
17.

Publisher Correction: The molecular landscape of head and neck cancer.

Leemans CR, Snijders PJF, Brakenhoff RH.

Nat Rev Cancer. 2018 Oct;18(10):662. doi: 10.1038/s41568-018-0057-9.

PMID:
30209307
18.

A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma.

Hussein AA, Forouzanfar T, Bloemena E, de Visscher J, Brakenhoff RH, Leemans CR, Helder MN.

Br J Cancer. 2018 Sep;119(6):724-736. doi: 10.1038/s41416-018-0233-4. Epub 2018 Aug 21.

PMID:
30131545
19.

The course of sexual interest and enjoyment in head and neck cancer patients treated with primary (chemo)radiotherapy.

Melissant HC, Jansen F, Schutte LER, Lissenberg-Witte BI, Buter J, Leemans CR, Sprangers MA, Vergeer MR, Laan ETM, Verdonck-de Leeuw IM.

Oral Oncol. 2018 Aug;83:120-126. doi: 10.1016/j.oraloncology.2018.06.016. Epub 2018 Jun 22.

20.

Quality assurance in head and neck surgery: special considerations to catch up.

Andry G, Hamoir M, Leemans CR.

Eur Arch Otorhinolaryngol. 2018 Aug;275(8):2145-2149. doi: 10.1007/s00405-018-5046-9. Epub 2018 Jun 29.

PMID:
29959567
21.

Nationwide study of patients with head and neck paragangliomas carrying SDHB germline mutations.

Rijken JA, Niemeijer ND, Leemans CR, Eijkelenkamp K, van der Horst-Schrivers ANA, van Berkel A, Timmers HJLM, Kunst HPM, Bisschop PHLT, van Dooren MF, Hes FJ, Jansen JC, Corssmit EPM, Hensen EF.

BJS Open. 2018 Feb 6;2(2):62-69. doi: 10.1002/bjs5.39. eCollection 2018 Apr.

22.

Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study.

Jansen F, Verdonck-de Leeuw IM, Cuijpers P, Leemans CR, Waterboer T, Pawlita M, Penfold C, Thomas SJ, Waylen A, Ness AR.

Psychooncology. 2018 Sep;27(9):2245-2256. doi: 10.1002/pon.4816. Epub 2018 Jul 23.

23.

The efficacy of Life Review Therapy combined with Memory Specificity Training (LRT-MST) targeting cancer patients in palliative care: A randomized controlled trial.

Kleijn G, Lissenberg-Witte BI, Bohlmeijer ET, Steunenberg B, Knipscheer-Kuijpers K, Willemsen V, Becker A, Smit EF, Eeltink CM, Bruynzeel AME, van der Vorst M, de Bree R, Leemans CR, van den Brekel MWM, Cuijpers P, Verdonck-de Leeuw IM.

PLoS One. 2018 May 15;13(5):e0197277. doi: 10.1371/journal.pone.0197277. eCollection 2018.

24.

Highlights from the Second International Symposium on HPV infection in head and neck cancer.

Wiegand S, Wichmann G, Golusinski W, Leemans CR, Klussmann JP, Dietz A.

Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1365-1373. doi: 10.1007/s00405-018-4954-z. Epub 2018 Mar 27. Review.

PMID:
29589141
25.

The molecular landscape of head and neck cancer.

Leemans CR, Snijders PJF, Brakenhoff RH.

Nat Rev Cancer. 2018 May;18(5):269-282. doi: 10.1038/nrc.2018.11. Epub 2018 Mar 2. Review. Erratum in: Nat Rev Cancer. 2018 Oct;18(10):662.

PMID:
29497144
26.

Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study.

Leijenaar RT, Bogowicz M, Jochems A, Hoebers FJ, Wesseling FW, Huang SH, Chan B, Waldron JN, O'Sullivan B, Rietveld D, Leemans CR, Brakenhoff RH, Riesterer O, Tanadini-Lang S, Guckenberger M, Ikenberg K, Lambin P.

Br J Radiol. 2018 Jun;91(1086):20170498. doi: 10.1259/bjr.20170498. Epub 2018 Mar 22.

PMID:
29451412
27.

Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.

Rietbergen MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, Leemans CR, Brakenhoff RH, Bloemena E.

Int J Cancer. 2018 Jul 15;143(2):283-288. doi: 10.1002/ijc.31315. Epub 2018 Mar 2.

PMID:
29441569
28.

Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.

Nauta IH, Rietbergen MM, van Bokhoven AAJD, Bloemena E, Lissenberg-Witte BI, Heideman DAM, Baatenburg de Jong RJ, Brakenhoff RH, Leemans CR.

Ann Oncol. 2018 May 1;29(5):1273-1279. doi: 10.1093/annonc/mdy060.

PMID:
29438466
29.

Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape.

de Bree R, Senft A, Coca-Pelaz A, Kowalski L, Lopez F, Mendenhall W, Quer M, Rinaldo A, Shaha AR, Strojan P, Takes RP, Silver CE, Leemans CR, Ferlito A.

Adv Ther. 2018 Feb;35(2):161-172. doi: 10.1007/s12325-018-0662-8. Epub 2018 Feb 2. Review.

PMID:
29396680
30.

Clinical value of 18 FDG PET/CT in screening for distant metastases in head and neck squamous cell carcinoma.

Deurvorst SE, Hoekstra OS, Castelijns JA, Witte BI, Leemans CR, de Bree R.

Clin Otolaryngol. 2018 Jun;43(3):875-881. doi: 10.1111/coa.13074. Epub 2018 Feb 20.

PMID:
29377508
31.

A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.

de Vos B, Rijken JA, Adank MA, Hoksbergen AWJ, Bayley JP, Leemans CR, Hensen EF.

Clin Otolaryngol. 2018 Jun;43(3):841-845. doi: 10.1111/coa.13059. Epub 2018 Jan 25.

PMID:
29292578
32.

Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck.

de Boer DV, Martens-de Kemp SR, Buijze M, Stigter-van Walsum M, Bloemena E, Dietrich R, Leemans CR, van Beusechem VW, Braakhuis BJM, Brakenhoff RH.

Oncotarget. 2017 May 16;8(58):97928-97940. doi: 10.18632/oncotarget.17880. eCollection 2017 Nov 17.

33.

Patient-reported physical activity and the association with health-related quality of life in head and neck cancer survivors.

van Nieuwenhuizen AJ, Buffart LM, van Uden-Kraan CF, van der Velden LA, Lacko M, Brug J, Leemans CR, Verdonck-de Leeuw IM.

Support Care Cancer. 2018 Apr;26(4):1087-1095. doi: 10.1007/s00520-017-3926-y. Epub 2017 Nov 21.

34.

European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers.

Plaschke CC, Bertino G, McCaul JA, Grau JJ, de Bree R, Sersa G, Occhini A, Groselj A, Langdon C, Heuveling DA, Cemazar M, Strojan P, Leemans CR, Benazzo M, De Terlizzi F, Wessel I, Gehl J.

Eur J Cancer. 2017 Dec;87:172-181. doi: 10.1016/j.ejca.2017.10.008.

PMID:
29156298
35.

Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?

Jansen F, Coupé VMH, Eerenstein SEJ, Leemans CR, Verdonck-de Leeuw IM.

Support Care Cancer. 2018 Apr;26(4):1221-1231. doi: 10.1007/s00520-017-3945-8. Epub 2017 Nov 3.

36.

Evaluation of vascular features of vocal cords proposed by the European Laryngological Society.

Šifrer R, Rijken JA, Leemans CR, Eerenstein SEJ, van Weert S, Hendrickx JJ, Bloemena E, Heuveling DA, Rinkel RNPM.

Eur Arch Otorhinolaryngol. 2018 Jan;275(1):147-151. doi: 10.1007/s00405-017-4791-5. Epub 2017 Oct 30.

37.

High number of chromosomal copy number aberrations inversely relates to t(11;19)(q21;p13) translocation status in mucoepidermoid carcinoma of the salivary glands.

Matse JH, Veerman ECI, Bolscher JGM, Leemans CR, Ylstra B, Bloemena E.

Oncotarget. 2017 Apr 20;8(41):69456-69464. doi: 10.18632/oncotarget.17282. eCollection 2017 Sep 19.

38.

Is there evidence for the added value and correct use of manual and automatically switching multimemory hearing devices? A scoping review.

de Graaff F, Huysmans E, Ket JCF, Merkus P, Goverts ST, Leemans CR, Smits C.

Int J Audiol. 2018 Mar;57(3):176-183. doi: 10.1080/14992027.2017.1385864. Epub 2017 Oct 10. Review.

PMID:
29017358
39.

Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables.

Mes SW, Te Beest D, Poli T, Rossi S, Scheckenbach K, van Wieringen WN, Brink A, Bertani N, Lanfranco D, Silini EM, van Diest PJ, Bloemena E, Leemans CR, van de Wiel MA, Brakenhoff RH.

Oncotarget. 2017 Jul 26;8(35):59312-59323. doi: 10.18632/oncotarget.19576. eCollection 2017 Aug 29.

40.

Durable usage of patient-reported outcome measures in clinical practice to monitor health-related quality of life in head and neck cancer patients.

Duman-Lubberding S, van Uden-Kraan CF, Jansen F, Witte BI, Eerenstein SEJ, van Weert S, de Bree R, Leemans CR, Verdonck-de Leeuw IM.

Support Care Cancer. 2017 Dec;25(12):3775-3783. doi: 10.1007/s00520-017-3808-3. Epub 2017 Jul 12.

41.

Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review.

Hussein AA, Helder MN, de Visscher JG, Leemans CR, Braakhuis BJ, de Vet HCW, Forouzanfar T.

Eur J Cancer. 2017 Sep;82:115-127. doi: 10.1016/j.ejca.2017.05.026. Epub 2017 Jun 24. Review.

PMID:
28654785
42.

Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial.

van der Hout A, van Uden-Kraan CF, Witte BI, Coupé VMH, Jansen F, Leemans CR, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM.

Trials. 2017 May 22;18(1):228. doi: 10.1186/s13063-017-1952-1.

43.

The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.

Rijken JA, Niemeijer ND, Jonker MA, Eijkelenkamp K, Jansen JC, van Berkel A, Timmers HJLM, Kunst HPM, Bisschop PHLT, Kerstens MN, Dreijerink KMA, van Dooren MF, van der Horst-Schrivers ANA, Hes FJ, Leemans CR, Corssmit EPM, Hensen EF.

Clin Genet. 2018 Jan;93(1):60-66. doi: 10.1111/cge.13055. Epub 2017 Sep 6.

PMID:
28503760
44.

The phenotype of SDHB germline mutation carriers: a nationwide study.

Niemeijer ND, Rijken JA, Eijkelenkamp K, van der Horst-Schrivers ANA, Kerstens MN, Tops CMJ, van Berkel A, Timmers HJLM, Kunst HPM, Leemans CR, Bisschop PH, Dreijerink KMA, van Dooren MF, Bayley JP, Pereira AM, Jansen JC, Hes FJ, Hensen EF, Corssmit EPM.

Eur J Endocrinol. 2017 Aug;177(2):115-125. doi: 10.1530/EJE-17-0074. Epub 2017 May 10.

PMID:
28490599
45.

Intravoxel incoherent motion magnetic resonance imaging in head and neck cancer: A systematic review of the diagnostic and prognostic value.

Noij DP, Martens RM, Marcus JT, de Bree R, Leemans CR, Castelijns JA, de Jong MC, de Graaf P.

Oral Oncol. 2017 May;68:81-91. doi: 10.1016/j.oraloncology.2017.03.016. Epub 2017 Apr 2. Review.

46.

A Review on Cost-Effectiveness and Cost-Utility of Psychosocial Care in Cancer Patients.

Jansen F, van Zwieten V, Coupé VM, Leemans CR, Verdonck-de Leeuw IM.

Asia Pac J Oncol Nurs. 2016 Apr-Jun;3(2):125-136. Review.

47.

The FA/BRCA Pathway Identified as the Major Predictor of Cisplatin Response in Head and Neck Cancer by Functional Genomics.

Martens-de Kemp SR, Brink A, van der Meulen IH, de Menezes RX, Te Beest DE, Leemans CR, van Beusechem VW, Braakhuis BJ, Brakenhoff RH.

Mol Cancer Ther. 2017 Mar;16(3):540-550. doi: 10.1158/1535-7163.MCT-16-0457. Epub 2016 Dec 15.

48.

Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.

Jansen F, Krebber AM, Coupé VM, Cuijpers P, de Bree R, Becker-Commissaris A, Smit EF, van Straten A, Eeckhout GM, Beekman AT, Leemans CR, Verdonck-de Leeuw IM.

J Clin Oncol. 2017 Jan 20;35(3):314-324. doi: 10.1200/JCO.2016.68.8739. Epub 2016 Dec 5.

PMID:
27918712
49.

Prophylactic exercises among head and neck cancer patients during and after swallowing sparing intensity modulated radiation: adherence and exercise performance levels of a 12-week guided home-based program.

Cnossen IC, van Uden-Kraan CF, Witte BI, Aalders YJ, de Goede CJ, de Bree R, Doornaert P, Rietveld DH, Buter J, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM.

Eur Arch Otorhinolaryngol. 2017 Feb;274(2):1129-1138. doi: 10.1007/s00405-016-4367-9. Epub 2016 Nov 3.

50.

Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck.

van Weert S, Reinhard R, Bloemena E, Buter J, Witte BI, Vergeer MR, Leemans CR.

Head Neck. 2017 Mar;39(3):456-463. doi: 10.1002/hed.24613. Epub 2016 Oct 24.

PMID:
27775851

Supplemental Content

Loading ...
Support Center